Celularity Inc. (NASDAQ:CELUW) Short Interest Update

Celularity Inc. (NASDAQ:CELUW) was the target of a significant decrease in short interest during the month of May. As of May 29th, there was short interest totaling 10,742 shares, a decrease of 55.9% from the May 14th total of 24,342 shares. Based on an average trading volume of 14,702 shares, the short-interest ratio is currently 0.7 days.

Celularity Stock Down 37.7%

Shares of CELUW stock traded down $0.00 during trading hours on Friday, reaching $0.00. The stock had a trading volume of 30,810 shares, compared to its average volume of 19,834. Celularity has a twelve month low of $0.00 and a twelve month high of $0.06. The firm has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.01.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.